Title: Distribution of Early-Stage Lymphedema and Risk Factors in Postoperative Patients with Breast Cancer: A Hospital Based Study
Authors:Dr Swodeep Mohant, Dr Krupa Sindhu Panda
DOI: http://dx.doi.org/10.18535/jmscr/v4i2.35
Abstract
Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. Lymphedema development, which affects the quality of life negatively, is defined as interstitial tissue effusion rich in protein as a result of failure in the lymphatic system in patients who undergo surgical treatment and radiotherapy (RT) for breast cancer. In the routine follow-up of the cases, the clinical and histopathological data and the data relating to the surgical procedure assessed at the 12th month were examined retrospectively, and arm measurements were made for lymphedema evaluation. In this study, we determining the early-stage postoperative lymphedema distribution and specifying the risk factors in its development.
Key words:Breast cancer, Lymphedema, & Risk Factor.
References
1. American Cancer Society. Available from: URL: http://www.cancer.org/
2. Szuba A, Achalu R, Rockson SG. Decongestive lymphatic therapy for patients with breast carcinoma associated lymphedema. Cancer 2002; 95:2260-2267.
3. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst 2001; 93:96-111.
4. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998; 83:2776-2781.
5. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: A three-year follow-up study. QJM 2005; 98:343-348.
6. Tracy GD, Reeve JS, Fitz S E, Rundle FF. Observation of the swollen arm after radical mastectomy. Aust NZ J Surg 1961;30:204-8.
7. Kissin MW, Querrci DR, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br J Surg 1986;73:580-4.
8. Hoe AL, Iven D, Royle GT, and Taylor I. Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg 1992;79: 261-2.
9. Pain SJ, Purushotham AD. Lymphedema following surgery for breast cancer. Br J Surg 2000; 87:1128-41.
10. Logan V. Incidence and prevalence of lymphedema: A literature review. J Clin Nurs 1995;4:213-9.
11. Ozalslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
12. Gerber LH. A review of measures of lymphedema. Cancer 1998; 83:2803-2804.
13. Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early- stage breast cancer. Arch Surg 2002;137:1253-7.
14. Johansson K, Holmostrom H, Nilsson I, Ingvar C, Albertsson M, Ekdahl C. Breast cancer patients’ experiences of lymphedema. Scan J Caring Sci 2003;17:35-42.
15. Park JH, Lee WH, Chung HS. J. Incidence and risk factors of breast cancer lymphoedema. Clin Nurs 2008; 17:1450-1459.
16. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clin Proc 2005; 80:1480-1484.
17. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema following breast cancer: Incidence, risk factors, and effect on upper-body function. J Clin Oncol 2008; 26:3536-3542.
18. Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, Raina V. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer 2004; 41:8-12.
19. Werner RS, McKormick B, Petrek J, Cox L, Cirrincione C, Gray JR, Yahalom J. Arm edema in conservatively managed breast cancer. Radiology 1991; 180:177-184.
20. Edwards TL. Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg 2000; 70:412-418.
21. Galler BM, Vacek PM, O’Brain P, Secker-Walker RH. Factors associated with arm swelling after breast cancer surgery. J Women’s Health 2003; 12:921-930.
22. Coen JJ, Taghian AG, Kachnic LA, Assaag SI, Powell SN. Risk of lympedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003; 55:1209-1215.
23. Querci della Rovere G, Ahmad I, Singh P, Ashley S, Daniels IR, Mortimer P. An audit of the incidence of arm lymphoedema after prophylactic level I/II axilliary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl 2003; 85:158-161
24. Arrault M, Vignes S. Risk factors for developing upper limb lymphoedema after breast cancer treatment. Bull Cancer 2006; 93:1001-1006.
25. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001; 92:1783-1787.
26. Schunemann H, Willich N. Lymphedema after breast carcinoma. A study of 5868 cases. Dtsch Med Wochenschr 1997; 122:536-541.
27. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 1990; 125:1144-1147.
28. Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KK. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002; 9:543-549.
29. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003; 138:482-487.
30. Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003; 29:341-350.
31. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE 2nd, Giuliano AE. Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13:491-500.
32. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br J Surg 1986; 73:580-584.
33. Lin PP, Alison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, Baker RR. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993; 11:1536-1544.
34. Keramapoulus A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D. Arm morbidity following treatment of breast cancer with total axillary dissection: A multivariated approach. Oncology 1993; 50:445-449.
35. Deutsch M, Flickinger C. Arm edema after lumpectomy and breast irradiation. Am J Clin Oncol 2003; 26:229-231.
36. Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, Uehlinger U, Infanger E, Burger D, Zuber M. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: A prospective Swiss multicenter study on 659 patients. Ann Surg 2007; 245:452-461.
37. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencanz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgens Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007; 25:3657-3663.
38. McLaughlin S, Wright M, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Patient perceptions and precautionary behaviors. J Clin Oncol 2008; 26:5220-5226.
39. Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006; 15:153-165.
40. Moffat FL Jr, Senofsky GM, Davis K, Clark KC, Robinson DS, Ketcham AS. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992; 51:8-13.
41. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004; 187:69-72.
42. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer 2001; 92:1783-1787.
43. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J 2004; 10:405-411.